An update from Cogstate Ltd ( (AU:CGS) ) is now available.
Cogstate Ltd has announced an update regarding its ongoing on-market buy-back program. As of March 25, 2025, the company has repurchased a total of 2,835,622 ordinary fully paid securities, with 8,608 bought back on the previous day. This buy-back initiative is part of Cogstate’s strategy to enhance shareholder value and optimize its capital structure.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, focusing on cognitive science and technology. The company provides digital cognitive assessment tools and services, primarily targeting pharmaceutical companies, healthcare providers, and research organizations.
YTD Price Performance: 30.29%
Average Trading Volume: 9,313
Technical Sentiment Signal: Sell
Current Market Cap: $151.3M
See more data about CGS stock on TipRanks’ Stock Analysis page.